Fetal gender and several cytokines are associated with the number of fetal cells in maternal blood - An observational study

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Schlütter, Jacob Mørup ^a   Kirkegaard, Ida ^a   Petersen, Olav Bjørn ^a   Larsen, Nanna ^b   Christensen, Britta ^c   Hougaard, David M ^b   Kølvraa, Steen ^d   Uldbjerg, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c FCMB ApS   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHORIONIC GONADOTROPIN BETA SUBUNIT; GAMMA INTERFERON; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTROPHIN 3; NEUROTROPHIN 4; PREGNANCY ASSOCIATED PLASMA PROTEIN A; RANTES; TRANSFORMING GROWTH FACTOR BETA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; CCL5 PROTEIN, HUMAN; IL5 PROTEIN, HUMAN;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CELL COUNT; CELL ISOLATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS; FETUS CELL; GENDER; GESTATIONAL AGE; HUMAN; MALE; MATERNAL AGE; MATERNAL BLOOD; OBSERVATIONAL STUDY; PLACENTA; PREECLAMPSIA; PREGNANT WOMAN; PREMATURITY; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; BLOOD; CELL LINEAGE; CELL SEPARATION; CELL TRACKING; CYTOLOGY; FETUS BLOOD; IMMUNOLOGY; PREGNANCY; SEX DIFFERENCE; SEXUAL DEVELOPMENT;

ADULT; CELL COUNT; CELL LINEAGE; CELL SEPARATION; CELL TRACKING; CHEMOKINE CCL5; FEMALE; FETAL BLOOD; FETUS; GESTATIONAL AGE; HUMANS; INTERLEUKIN-2; INTERLEUKIN-5; MALE; PREGNANCY; SEX CHARACTERISTICS; SEX FACTORS;

EID: 84906961204     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106934     Document Type: Article

References (30)

1. Mujezinovic F, Alfirevic Z (2007) Procedure-related complications of amniocentesis and chorionic villous sampling: A systematic review. Obstet Gynecol 110: 687-694.
2. Kleihauer E, Braun H, Betke K (1957) Demonstration of fetal hemoglobin in erythrocytes of a blood smear. Klin Wochenschr 35: 637-638.
3. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, et al. (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
4. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH (2013) Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: Relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 41: 26-32.
5. Kolvraa S, Christensen B, Lykke-Hansen L, Philip J (2005) The fetal erythroblast is not the optimal target for non-invasive prenatal diagnosis: Preliminary results. J Histochem Cytochem 53: 331-336.
6. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, et al. (2006) Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52: 2211-2218.
7. Tsaliki E, Papageorgiou EA, Spyrou C, Koumbaris G, Kypri E, et al. (2012) MeDIP real-time qPCR of maternal peripheral blood reliably identifies trisomy 21. Prenat Diagn 32: 996-1001.
8. Hahn S, Lapaire O, Tercanli S, Kolla V, Hosli I (2011) Determination of fetal chromosome aberrations from fetal DNA in maternal blood: Has the challenge finally been met? Expert Rev Mol Med 13: e16.
9. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, et al. (2011) DNA sequencing of maternal plasma to detect down syndrome: An international clinical validation study. Genet Med 13: 913-920.
10. Taylor JB, Chock VY, Hudgins L (2014) NIPT in a clinical setting: An analysis of uptake in the first months of clinical availability. J Genet Couns 23: 72-78.
11. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 93: 705-708.
12. Kolvraa S, Christensen B, Lykke-Hansen L, Philip J (2005) The fetal erythroblast is not the optimal target for non-invasive prenatal diagnosis: Preliminary results. J Histochem Cytochem 53: 331-336.
13. Christensen B, Kolvraa S, Lykke-Hansen L, Lorch T, Gohel D, et al. (2003) Studies on the isolation and identification of fetal nucleated red blood cells in the circulation of pregnant women before and after chorion villus sampling. Fetal Diagn Ther 18: 376-384.
14. Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, et al. (2002) Fetal gender and aneuploidy detection using fetal cells in maternal blood: Analysis of NIFTY I data. national institute of child health and development fetal cell isolation study. Prenat Diagn 22: 609-615.
15. Oudejans CB, Tjoa ML, Westerman BA, Mulders MA, Van Wijk IJ, et al. (2003) Circulating trophoblast in maternal blood. Prenat Diagn 23: 111-116.
16. Krabchi K, Gros-Louis F, Yan J, Bronsard M, Masse J, et al. (2001) Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 60: 145-150.
17. Guetta E, Gordon D, Simchen MJ, Goldman B, Barkai G (2003) Hematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: Detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation. Blood Cells Mol Dis 30: 13-21.
18. Brinch M, Hatt L, Singh R, Moller K, Sommer S, et al. (2012) Identification of circulating fetal cell markers by microarray analysis. Prenat Diagn 32: 742-751.
19. Hatt L, Brinch M, Singh R, Moller K, Lauridsen RH, et al. (2014) Characterization of fetal cells from the maternal circulation by microarray gene expression analysis - could the extravillous trophoblasts be a target for future cell-based non-invasive prenatal diagnosis? Fetal Diagn Ther 35: 218-27.
20. Hatt L, Brinch M, Singh R, Moller K, Lauridsen RH, et al. (2014) A new marker set that identifies fetal cells in maternal circulation with high specificity. Prenat Diagn DOI: 10.1002/pd.4429.
21. Gammill HS, Guthrie KA, Aydelotte TM, Waldorf KM, Nelson JL (2010) Effect of parity on fetal and maternal microchimerism: Interaction of grafts within a host? Blood 116: 2706-2712.
22. Hamada H, Arinami T, Kubo T, Hamaguchi H, Iwasaki H (1993) Fetal nucleated cells in maternal peripheral blood: Frequency and relationship to gestational age. Hum Genet 91: 427-432.
23. Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, et al. (2010) The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol 87: 67-73.
24. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, et al. (2005) Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51: 1854-1866.
25. Tikkanen M, Metsaranta M, Gissler M, Luukkaala T, Hiilesmaa V, et al. (2010) Male fetal sex is associated with earlier onset of placental abruption. Acta Obstet Gynecol Scand 89: 916-923.
26. Elsmen E, Kallen K, Marsal K, Hellstrom-Westas L (2006) Fetal gender and gestational-age-related incidence of pre-eclampsia. Acta Obstet Gynecol Scand 85: 1285-1291.
27. Athayde N, Romero R, Maymon E, Gomez R, Pacora P, et al. (1999) A role for the novel cytokine RANTES in pregnancy and parturition. Am J Obstet Gynecol 181: 989-994.
28. Sharma D, Singh A, Trivedi SS, Bhattacharjee J (2010) Role of endothelin and inflammatory cytokines in pre-eclampsia - A pilot north indian study. Am J Reprod Immunol.
29. Vogel I, Goepfert AR, Thorsen P, Skogstrand K, Hougaard DM, et al. (2007) Early second-trimester inflammatory markers and short cervical length and the risk of recurrent preterm birth. J Reprod Immunol 75: 133-140.
30. Adams Waldorf KM, Gammill HS, Lucas J, Aydelotte TM, Leisenring WM, et al. (2010) Dynamic changes in fetal microchimerism in maternal peripheral blood mononuclear cells, CD4+ and CD8+ cells in normal pregnancy. Placenta 31: 589-594.